138 related articles for article (PubMed ID: 9016988)
1. Neuroendocrine carcinomas of the lung and role of 111In-DTPA-octreotide scintigraphy: preliminary results.
Oliaro A; Filosso PL; Bello M; Casadio C; Muni A; Greco B; Bertuccio G; Bisi G; Maggi G
J Cardiovasc Surg (Torino); 1996 Dec; 37(6):653-6. PubMed ID: 9016988
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary results on the use of scintigraphy with radiolabelled octreotide as diagnostic method in neuroendocrine and nonendocrine neoplasms of the lung].
Oliaro A; Filosso PL; Bellò M; Casadio C; Muni A; Angusti T; Masaneo I; Bisi G; Maggi G
Minerva Chir; 1997 Nov; 52(11):1335-8. PubMed ID: 9489331
[TBL] [Abstract][Full Text] [Related]
3. Use of 111In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine and non-neuroendocrine tumors of the lung. Preliminary results.
Oliaro A; Filosso PL; Bello M; Casadio C; Angusti T; Masaneo I; Maggi G; Bisi G
J Cardiovasc Surg (Torino); 1997 Jun; 38(3):313-5. PubMed ID: 9219485
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m sestamibi and In-111 DTPA octreotide uptake in breast carcinoma with neurendocrine differentiation.
Rubini G; D'Eredità G
Clin Nucl Med; 2000 Jun; 25(6):482-3. PubMed ID: 10836705
[TBL] [Abstract][Full Text] [Related]
5. 111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer.
Bombardieri E; Chiti A; Crippa F; Seregni E; Cataldo I; Maffioli L; Soresi E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):104-7. PubMed ID: 9002763
[TBL] [Abstract][Full Text] [Related]
6. [111-indium DTPA octreotide scintigraphy in colorectal liver metastases].
Seifert JK; Görges R; Bockisch A; Junginger T
Langenbecks Arch Chir; 1997; 382(6):332-6. PubMed ID: 9498205
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy.
Bombardieri E; Crippa F; Cataldo I; Chiti A; Seregni E; Soresi E; Boffi R; Invernizzi G; Buraggi GL
Eur J Cancer; 1995; 31A(2):184-8. PubMed ID: 7718323
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor imaging in small cell lung cancer.
Berenger N; Moretti JL; Boaziz C; Vigneron N; Morere JF; Breau JL
Eur J Cancer; 1996 Jul; 32A(8):1429-31. PubMed ID: 8869110
[TBL] [Abstract][Full Text] [Related]
9. 111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer.
Crippa F; Bombardieri E; Chiti A; Soresi E; Boffi R; Buraggi GL
J Nucl Biol Med (1991); 1994 Dec; 38(4):576-8. PubMed ID: 7786920
[TBL] [Abstract][Full Text] [Related]
10. Intensification of 111In-DTPA-octreotide scintigraphy by means of pretreatment with cold octreotide in small cell lung cancer.
Soresi E; Invernizzi G; Boffi R; Possa M; Bombardieri E; Ciavarella GP; Liuzzi A
Lung Cancer; 1997 Jul; 17(2-3):231-8. PubMed ID: 9237158
[TBL] [Abstract][Full Text] [Related]
11. Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
Kurtaran A; Scheuba C; Kaserer K; Schima W; Czerny C; Angelberger P; Niederle B; Virgolini I
J Nucl Med; 1998 Nov; 39(11):1907-9. PubMed ID: 9829581
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor imaging.
Kwekkeboom DJ; Krenning EP
Semin Nucl Med; 2002 Apr; 32(2):84-91. PubMed ID: 11965603
[TBL] [Abstract][Full Text] [Related]
13. The value of octreotide scintigraphy in patients with lung cancer.
Kwekkeboom DJ; Kho GS; Lamberts SW; Reubi JC; Laissue JA; Krenning EP
Eur J Nucl Med; 1994 Oct; 21(10):1106-13. PubMed ID: 7828621
[TBL] [Abstract][Full Text] [Related]
14. Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide.
Andersson P; Forssell-Aronsson E; Johanson V; Wängberg B; Nilsson O; Fjälling M; Ahlman H
J Nucl Med; 1996 Dec; 37(12):2002-6. PubMed ID: 8970523
[TBL] [Abstract][Full Text] [Related]
15. Clinical diagnostic application of 111In-DTPA-octreotide scintigraphy in small cell lung cancer.
Vaccarili M; Lococo A; Fabiani F; Staffilano A
Tumori; 2000; 86(3):224-8. PubMed ID: 10939603
[TBL] [Abstract][Full Text] [Related]
16. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled somatostatin analog scintigraphy in oncology and immune diseases: an overview.
Kwekkeboom DJ; Krenning EP
Eur Radiol; 1997; 7(7):1103-9. PubMed ID: 9265684
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptors in meningiomas: a scintigraphic study using 111In-DTPA-D-Phe-1-octreotide.
Maini CL; Tofani A; Sciuto R; Carapella C; Cioffi R; Crecco M
Nucl Med Commun; 1993 Jul; 14(7):550-8. PubMed ID: 8355914
[TBL] [Abstract][Full Text] [Related]
19. Comparison of indium-111 octreotide and thallium-201 scintigraphy in patients mammographically suspected of having breast cancer: preliminary results.
Vural G; Unlü M; Atasever T; Ozur I; Ozdemir A; Gökçora N
Eur J Nucl Med; 1997 Mar; 24(3):312-5. PubMed ID: 9143470
[TBL] [Abstract][Full Text] [Related]
20. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
